Detalles de la búsqueda
1.
Clinical association of metabolic syndrome, C-reactive protein and testosterone levels with clinically significant prostate cancer.
J Cell Mol Med
; 23(2): 934-942, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30450757
2.
Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets.
Mol Oncol
; 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38790138
3.
Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL.
BMJ Open
; 9(11): e031032, 2019 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31722940
Resultados
1 -
3
de 3
1
Próxima >
>>